Ovarian cancer rates declining in breast cancer survivors

January 8, 2013
Ovarian cancer rates declining in breast cancer survivors
Primary ovarian cancer incidence is declining in the United States, both among the general population and among breast cancer survivors, according to research published online Jan. 2 in the Journal of Clinical Oncology.

(HealthDay)—Primary ovarian cancer incidence is declining in the United States, both among the general population and among breast cancer survivors, according to research published online Jan. 2 in the Journal of Clinical Oncology.

Sara J. Schonfeld, Ph.D., M.P.H., from the National Institutes of Health in Bethesda, Md., and colleagues analyzed data from the Surveillance, Epidemiology, and End Results program (1973 to 2008) to examine the incidence of second primary ovarian cancers among .

The researchers found that, over the entire study period, the standardized incidence ratios (SIRs) for second primary were elevated (SIR, 1.24), while the absolute rates decreased by about 1 percent per year. Similar secular trends were observed for second ovarian cancers following estrogen receptor (ER)-positive and ER-negative breast cancers, although there were significant variations in the age-specific patterns based on ER expression. Women aged younger than 50 years with ER-negative breast cancer had the largest SIR (SIR, 4.35).

"Persistently elevated SIRs along with decreasing absolute rates over the entire study period suggest that ovarian cancers in both the general population and survivors of are declining in parallel, possibly because of common risk factor exposures," the authors write. "Analytic studies are needed to further assess the parallel overall trends and the age-specific interaction by ER expression."

Explore further: BU identifies contributors to high incidence of breast cancer in African-American women

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Vitamin D influences racial differences in breast cancer risk

April 4, 2012

American women of African ancestry are more likely than European Americans to have estrogen receptor (ER) negative breast cancer. There continues to be discussion about the role of low levels of vitamin D in the development ...

Recommended for you

Study: Colonoscopy after 75 may not be worth it

September 26, 2016

(HealthDay)—A colonoscopy can find and remove cancerous growths in the colon, but it may not provide much cancer prevention benefit after the age of 75, a new study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.